Avant Diagnostics, Inc. (OTCQB: AVDX) is a medical diagnostic technology company that specializes in large panel biomarker screening. The company is seeking FDA approval of a test for early detection for pre-symptomatic ovarian cancer.
View Top Employees from Avant Diagnostics, Inc.Website | http://www.avantdiagnostics.com |
Ticker | AVDX |
Revenue | $38000 |
Employees | 1 (1 on RocketReach) |
Founded | 2012 |
Address | 1050 30th St NW Ste 107, Washington, District of Columbia 20007, US |
Phone | (203) 393-9441 |
Fax | (888) 850-2792 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Diagnostics, Health Care, Medical |
Web Rank | 13 Million |
Keywords | Early Stage Drug Development Companies, Avant Diagnostics |
Competitors | AmberGen, BioMedomics, Inc., Evoke Neuroscience, MetaStat, Inc., Provista Diagnostics |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 33 Companies |
Looking for a particular Avant Diagnostics, Inc. employee's phone or email?
The Avant Diagnostics, Inc. annual revenue was $38000 in 2024.
1 people are employed at Avant Diagnostics, Inc..
Avant Diagnostics, Inc. is based in Washington, District of Columbia.
The NAICS codes for Avant Diagnostics, Inc. are [54171, 541, 541711, 54, 5417, 33].
The SIC codes for Avant Diagnostics, Inc. are [38, 384].